Novo Nordisk A/S/ DK0060534915 /
2/1/2023 5:00:00 PM | Chg. +0.80 | Volume | Bid5:00:00 PM | Ask5:00:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
944.30DKK | +0.08% | 1.55 mill. Turnover: 597.57 mill. |
-Bid Size: - | -Ask Size: - | 2681.07 bill.DKK | 1.10% | 45.33 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 20.79 DKK | 15.18% |
EPS Diluted: | 20.74 DKK | 15.16% |
Revenues per Share: | 61.31 DKK | 12.71% |
Book Value per Share: | 30.80 DKK | 13.53% |
Cash Flow per Share: | 23.95 DKK | 7.59% |
Dividend per Share: | 10.40 DKK | 14.29% |
Total | in mill. | |
Revenues: | 140,800.00 DKK | 10.91% |
Net Income: | 47,757.00 DKK | 13.33% |
Operating Cash Flow: | 55,000.00 DKK | - |
Cash and Cash Equivalents: | 10,720.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 45.33 | 35.35 |
P/S Ratio: | 15.37 | 11.99 |
P/BV ratio: | 30.59 | 23.86 |
P/CF Ratio: | 39.35 | 30.69 |
PEG: | 2.99 | 2.33 |
Earnings Yield: | 2.21% | 2.83% |
Dividend Yield: | 1.10% | 1.42% |
Market Capitalization | ||
Market Capitalization: | 2681.07 bill. DKK | 1688 bill. DKK |
Free Float Market Cap.: | 1442.3 bill. DKK | 1124.88 bill. DKK |
Market Cap. / Employee: | 44.65 mill. DKK | 34.82 mill. DKK |
Shares Outstanding: | 2.31 bill. |
Profitability
Gross Profit Margin: | 83.20% |
EBIT Margin: | 41.65% |
Net Profit Margin: | 33.92% |
Return on Equity: | 67.50% |
Return on Assets: | 24.55% |
Financial Strength
Liquidity I / Cash Ratio: | 10.77% |
Liquidity II / Quick Ratio: | 51.61% |
Liquidity III / Current Ratio: | 86.01% |
Debt / Equity Ratio: | 174.94% |
Dynam. Debt / Equity Ratio: | 225.02% |
Efficiency
Employees: | 48,478 |
Personal Expenses / Employee: | 753,578.94 DKK |
Revenues / Employee: | 2,904,410.25 DKK |
Net Income / Employee: | 985,127.27 DKK |
Total Assets / Employee: | 4,012,294.24 DKK |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | IFRS |
Currency: | DKK |